Medpage Today on MSN
Novel HER2 Drug Shrinks Lung Cancer Tumors in Early Trial
Approved targeted drugs for HER2 -mutant NSCLC include trastuzumab deruxtecan (T-DXd, Enhertu) -- which is highly effective ...
Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but ...
MedPage Today on MSN
Global Study Reports Rise in Several Cancers Among Adults of All Ages
From 2003-2017, incidence rates for six of 13 cancers assessed rose among younger adults (ages 20-49) in over 75% of the ...
Anti-tumor activity was observed in heavily pretreated mCRPC patients across all dose cohorts; in 22 patients who completed at least 2 cycles of ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
QTX3034 monotherapy and the QTX3034-cetuximab combination demonstrated favorable safety profiles and clear clinical proof of concept, including ...
"It wasn’t until I developed a random blind spot in my eye that my mom took me to the ER. They ordered a head CT that caught ...
TheHealthSite.com on MSN
Dipika Kakar Health Update: Opens About Intense Hair Loss, Thyroid Fluctuations And Mouth Ulcers During Cancer Therapy
Dipika Kakar recently opened up about her intense hair loss, thyroid issues, fluctuations, and more. Here's her health update ...
Stocktwits on MSN
Verastem Stock Ignites Retail Buzz After Early Cancer Drug Data Show Tumor Reduction, Mild Side Effects
Verastem reported early trial data showing its experimental oral therapy targeting KRAS-driven cancers was well-tolerated, ...
The RaKSA initiative aims to empower community health workers to screen for three major cancers breast, cervical, and oral in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback